Skip to main content

Table 4 Circulating tumor cell (CTC) distribution

From: Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

CTC #

CellSearchâ„¢

Ariol®

0

35 (71%)

25 (51%*)

1 to 4

8 (16%)

16 (33%*)

≥ 5

6 (12%)

8 (16%)

Positive %

29

49*

  1. * Significant difference (p < 0.01) with Z-test.
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us